Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC) Meeting Abstract


Authors: Seidman, A. D.; Conlin, A. K.; Bach, A.; Brufsky, A. M.; Saleh, M. N.; Lake, D.; Dickler, M. N.; D'Andrea, G.; Traina, T. A.; Hudis, C. A.
Abstract Title: Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 52s
Language: English
ACCESSION: WOS:000208457400352
DOI: 10.1200/jco.2008.26.15_suppl.1047
PROVIDER: wos
Notes: Meeting Abstract: 1047 -- Source: Wos
Altmetric Score
MSK Authors
  1. Andrew D Seidman
    244 Seidman
  2. Clifford Hudis
    840 Hudis
  3. Ariadne Bach
    56 Bach
  4. Diana E Lake
    70 Lake
  5. Maura N Dickler
    237 Dickler
  6. Alison Katherine Conlin
    18 Conlin
  7. Tiffany A Traina
    153 Traina